Acetylcholinesterase and butyrylcholinesterase glycoforms are biomarkers of Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 3, Issue 3, 2001, Pages 323-328

  Saez Valero J ^a   Small, D H ^a  

^a INSTITUTO DE NEUROCIENCIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; BIOLOGICAL MARKER; CHOLINESTERASE;

ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ENZYME GLYCOSYLATION; HUMAN; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL;

EID: 0034971792     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2001-3307     Document Type: Article

References (42)

1. Decreased CSF acetylcholinesterase activity in Alzheimer's disease
2. Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development - A study of molecular forms
3. Molecular forms of acetylcholinesterase in senile dementia of Alzheimer's type, selective loss of the intermediate (10S) form
4. The cholinergic hypothesis of geriatric memory dysfunction
5. Molecular forms of acetylcholinesterase in brain, nerve and muscle, nature, localization and dynamics
6. Interaction of AChE with lens culinaris agglutinin reveals differences in glycosylation of molecular forms in sarcoplasmic reticulum membrane subfractions
7. Beta-amyloid levels predict cholinesterase activity in human cerebrospinal fluid
8. Consensus report of the working group on: "Molecular and biochemical markers of Alzheimer's disease"
9. Selective loss of central cholinergic neurons in Alzheimer's disease
10. Distribution of the molecular forms of acetylcholinesterase in human brain, alterations in dementia of the Alzheimer type
11. The human gene encoding acetylcholinesterase is located on the long arm of chromosome 7
12. Diagnosis of dementias using partial least squares discriminant analysis
13. Structural roles of acetylcholinesterase variants in biology and pathology
14. Cellular localization of the molecular forms of acetylcholinesterase in rat pheochromocytoma PC12 cells treated with nerve growth factor
15. Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: A study in Japan
16. Acute stress facilitates long-lasting changes in cholinergic gene expression
17. Different glycosylation in acetylcholinesterases from mammalian brain and erythrocytes
18. Lectins as molecules and as tools
19. Regulation of acetylcholinesterase mRNA stability by calcium during differentiation from myoblasts to myotubes
20. Molecular and cellular biology of cholinesterases
21. Treatment of Alzheimer's disease
22. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
23. Interactions with lectins indicate differences in the carbohydrate composition of the membrane-bound enzymes acetylcholinesterase and 5-nucleotidase in different cell types
24. Acetylcholinesterase-rich pyramidal neurons in the human neocortex and hippocampus, absence at birth, development during the life span, and dissolution in Alzheimer's Disease
25. Colocalization of cholinesterases with β amyloid protein in aged and Alzheimer's brains
26. Alzheimer's disease: A description of the structural lesions
27. Intracellular transport, sorting and turnover of acetylcholinesterase. Evidence for an endoglycosidase H-sensitive form in Golgi apparatus, sarcoplasmic reticulum, and clathrin-coated vesicles and its rapid degradation by a non-lysosomal mechanism
28. Altered glycosylation of acetylcholinesterase in Alzheimer lumbar cerebrospinal fluid
29. An unusually glycosylated form of acetylcholinesterase is a CSF biomarker for Alzheimer's disease
30. Glycosylation of acetylcholinesterase as diagnostic marker for Alzheimer's disease
31. Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease
32. Altered glycosylation of cerebrospinal fluid butyrylcholinesterase in Alzheimer's disease
33. The amyloid β-protein of Alzheimer's disease increases acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cells
34. Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT 100) of the beta-amyloid protein precursor of Alzheimer's disease
35. Non-classical actions of cholinesterases: Role in cellular differentiation, tumorigenesis and Alzheimer's disease
36. Molecular cloning and construction of the coding region for human acetylcholinesterase reveals a G+C-rich attenuating structure
37. Role of genetics in tests of genotype, status, and disease progression in early-onset Alzheimer's disease
38. The cholinesterases: From genes to proteins
39. Ricinus communis agglutinin I reacting and non-reacting butyrylcholinesterase in cerebrospinal fluid
40. Amyloid beta protein potentiates Ca2+ influx through L-type voltage-sensitive Ca2+ channels: A possible involvement of free radicals
41. Senile plaques, staining for acetylcholinesterase and A4 protein, a comparative study in the hippocampus and entorhinal cortex
42. Glycosylation of cholinesterases and its alteration in some pathological states